comparemela.com

Wall Street analysts forecast that Artelo Biosciences, Inc. (NASDAQ:ARTL – Get Rating) will report earnings per share of ($0.06) for the current quarter, according to Zacks. Zero analysts have made estimates for Artelo Biosciences’ earnings. Artelo Biosciences reported earnings per share of ($0.11) in the same quarter last year, which suggests a positive year over […]

Related Keywords

Artelo Bioscience ,Artelo Biosciences ,Geode Capital Management ,Virtu Financial ,Zacks Investment Research ,Renaissance Technologies ,Nasdaq ,Vanguard Group Inc ,Artelo Biosciences Inc ,Artelo Biosciences Company Profile Get Rating ,Citadel Advisors ,Wall Street ,Get Rating ,Investment Research ,Capital Management ,Biosciences Company Profile ,Synthetic Cannabinoid Agonist ,Nasdaq Artl ,Apartl ,Medical ,Ratings ,Consensus ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.